128 related articles for article (PubMed ID: 16834932)
21. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
[TBL] [Abstract][Full Text] [Related]
23. Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
Shariat SF; Marberger MJ; Lotan Y; Sanchez-Carbayo M; Zippe C; Lüdecke G; Boman H; Sawczuk I; Friedrich MG; Casella R; Mian C; Eissa S; Akaza H; Serretta V; Huland H; Hedelin H; Raina R; Miyanaga N; Sagalowsky AI; Roehrborn CG; Karakiewicz PI
J Urol; 2006 Sep; 176(3):919-26; discussion 926. PubMed ID: 16890655
[TBL] [Abstract][Full Text] [Related]
24. [Expression of SSX2 gene in human urologic neoplasms].
Du P; Yu LZ; Ma M; Geng L; Wang XS; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):379-81. PubMed ID: 15854347
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
26. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
Jamshidian H; Kor K; Djalali M
Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
[TBL] [Abstract][Full Text] [Related]
27. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
Lam AK; Saleh S; Smith RA; Ho YH
Hum Pathol; 2008 Aug; 39(8):1229-33. PubMed ID: 18547619
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
30. Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder.
Passerotti CC; Bonfim A; Martins JR; Dall'Oglio MF; Sampaio LO; Mendes A; Ortiz V; Srougi M; Dietrich CP; Nader HB
Eur Urol; 2006 Jan; 49(1):71-5. PubMed ID: 16310928
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
[TBL] [Abstract][Full Text] [Related]
32. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
33. [The diagnosis and monitoring of transitional cell cancer of the urinary tract through nuclear matrix protein 22].
Chen HQ; Han CZ; Du LL; Cui Y; Pang DZ; Jing JX; Zhao XW; Tian BG; Mi ZG
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():84-6. PubMed ID: 17767866
[TBL] [Abstract][Full Text] [Related]
34. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
Song T; Hong BF; Gao JP; Cai W; Wang CY
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
[TBL] [Abstract][Full Text] [Related]
35. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
Shen C; Hu L; Xia L; Li Y
Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
[TBL] [Abstract][Full Text] [Related]
36. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
[TBL] [Abstract][Full Text] [Related]
37. [Changes of urinary enzyme activity in cancer of the urinary bladder].
Nizamova RS
Vopr Onkol; 2006; 52(4):455-7. PubMed ID: 17024822
[TBL] [Abstract][Full Text] [Related]
38. [The study of relationship between nuclear metrix protein 22 urinary level and the grade and stage of bladder transitional cell carcinoma].
Xin DQ; You R; Ding Y; Liu LQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):681-3. PubMed ID: 16784679
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
[TBL] [Abstract][Full Text] [Related]
40. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P
Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
